{
    "nct_id": "NCT05044975",
    "official_title": "Improving Sleep in Gynecologic Cancer Survivors",
    "inclusion_criteria": "* History of Stage I, II, or III gynecologic cancer\n* Age 18+ years\n* English language proficiency\n* Current sleep disturbance demonstrated by a Pittsburgh Sleep Quality Index (PSQI) score > 5\n* Usual sleep onset time between 9:00PM and 3:00AM\n* Reliable telephone and Internet access\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Stage IV disease\n* Diagnosed or suspected psychiatric or medical condition that may interfere with participation (e.g., psychosis, dementia, bipolar disorder, abuse of alcohol or illicit substances within the past 6 months, narrow angle glaucoma, retinal disorders, epilepsy or a similar condition)\n* Diagnosed sleep apnea, narcolepsy, periodic limb movement disorder, or restless legs syndrome unless well controlled\n* Use of medications that may be contraindications for study procedures due to safety concerns or due to potential impact on intervention efficacy or assessment validity (e.g., sedatives/hypnotics), to be identified on a case-by-case basis\n* Shift worker\n* Severe physical or cognitive impairment (â‰¥ 2 errors on a brief six-item version of the Mini Mental State Exam [MMSE] or Patient Reported Functional Status [PRFS] score > 2, which is based on the Eastern Cooperative Oncology Group [ECOG]but has been modified to be in lay language)\n* Plans to travel across 3 or more meridians/time zones during the 6 intervention weeks or plans to cross any meridians/time zones during the 2 weeks leading up to wearing an actiwatch.\n* History of a primary diagnosis of a distinct non-gynecologic or non-skin cancer other than a non-melanoma skin cancer within the 5 years prior to enrollment\n* For participants with Stage III ovarian cancer: less than 2 years post-completion of primary gynecologic cancer treatment and/or less than 60 days post-surgery. For patients with any other gynecologic cancer/stage: less than 30 days post-completion of primary gynecologic cancer treatment and/or less than 60 days post-surgical intervention (e.g., hysterectomy)\n* Male\n* Have received CBT-I or systematic bright light therapy within the past 6 months",
    "miscellaneous_criteria": ""
}